Mechanism of thrombosis caused by sclerotherapy of esophageal varices using sodium tetradecyl sulphate
- PMID: 1344580
- DOI: 10.1007/BF00591179
Mechanism of thrombosis caused by sclerotherapy of esophageal varices using sodium tetradecyl sulphate
Abstract
The mechanism of thrombosis following intravariceal injection of sodium tetradecyl sulphate (S.T.D.) was investigated with respect to effects on the vascular endothelium, the coagulation cascade, and platelet function. Using an umbilical cord model designed to simulate blood flow over the endothelium, it was found that S.T.D. is a potent toxin for endothelial cells in that brief exposure to even low concentrations of the agent were effective in stripping endothelium over a considerable distance, exposing highly thrombogenic endothelium in the process. Effects on coagulation and platelet function were found to be dependent on concentration. Diluted S.T.D. induced a hypercoagulable state, possibly in consequence of a selective inhibition of the physiological anticoagulant, protein C, and promoted platelet aggregation. Higher concentrations inactivated the coagulation cascade and lysed platelets completely. These results suggest that intravariceal infusion of S.T.D. at considerable dilution may be at least as effective in inducing thrombosis as standard dosage, and possibly more so.
Similar articles
-
[Sodium tetradecyl sulfate as a sclerosing solution in the therapy of esophageal varices].Nihon Rinsho. 1990 Apr;48(4):722-6. Nihon Rinsho. 1990. PMID: 2366359 Japanese. No abstract available.
-
Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.Indian J Med Res. 2001 Jun;113:228-33. Indian J Med Res. 2001. PMID: 11816957 Clinical Trial.
-
Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.Gastrointest Endosc. 1998 Mar;47(3):235-9. doi: 10.1016/s0016-5107(98)70319-0. Gastrointest Endosc. 1998. PMID: 9540875 Clinical Trial.
-
Sclerotherapy of telangiectases using sodium tetradecyl sulfate (Sotradecol).N C Med J. 1996 Jan-Feb;57(1):42-6. N C Med J. 1996. PMID: 8821717 Review. No abstract available.
-
Sclerosants for variceal sclerotherapy: a critical appraisal.Am J Gastroenterol. 1990 Jun;85(6):641-9. Am J Gastroenterol. 1990. PMID: 2191592 Review.
Cited by
-
Tranexamic acid-fatty alcohol polyoxyethylene ether conjugation/PVA foam for venous sclerotherapy via vascular damage and inhibiting plasmin system.Acta Pharm Sin B. 2025 Jun;15(6):3291-3304. doi: 10.1016/j.apsb.2025.03.032. Epub 2025 Mar 18. Acta Pharm Sin B. 2025. PMID: 40654351 Free PMC article.
-
Ultrasound Elastography for Determination of the Age of Venous Thrombi. Evaluation of Thrombus Evolution in Patients After Sclerotherapy.Pol J Radiol. 2017 Feb 13;82:88-91. doi: 10.12659/PJR.899517. eCollection 2017. Pol J Radiol. 2017. PMID: 28289480 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources